Skip to main content

Genesis Enterprise System 2.5, TotalLab, NetAffx, OME 2.4.0, BRB-ArrayTools 3.2.3, eArray 3.0

Premium

Gene Logic has released Genesis Enterprise System 2.5. Users can import and analyze Affymetrix GeneChip data and annotate their samples using the system, and subscribers to Gene Logic’s BioExpress and ToxExpress databases can use it to analyze, manage, and store large amounts of array data and associated clinical, experimental, and genomic information.


Nonlinear Dynamics said last week that its TotalLab 1D gel image-analysis software is now compatible with the Apple Macintosh by using Virtual PC for Mac v7.0.


Affymetrix said that it will release an annotation update for its NetAffx analysis center in mid-March. The update will include new searches based on MeSH terms under “All Description” searches, and will provide access to the updated GenMAPP pathways. In addition, Entrez Gene will become the primary source of annotation data for the NetAffx Analysis Center. Mapping 10K and 100K array annotation support will be updated to NCBI Build 35 and dbSNP Build 123.


The OME (Open Microscopy Environment) project has released OME 2.4.0 at http://cvs.openmicroscopy.org.uk. The release supports more advanced image analysis and classification and also includes a number of enhancements to improve the performance of the system.


Version 3.2.3 of BRB-ArrayTools is available from the National Cancer Institute at http://linus.nci.nih.gov/~brb/download.htm. Improvements include a new plug-in for regression analysis of time series data and several bug fixes.


Agilent Technologies has launched eArray 3.0, a free Web portal for designing custom microarrays. The portal offers customers access to Agilent’s genomic content, annotation information, and probe sequences, and enables them to design custom microarrays using catalog probes, probes from their own sources, or a combination of both. Further information is available at http://earray.chem.agilent.com.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.